Health experts, caregivers and patients testify in support of the proposal at MA Department of Public Health hearingYesterday ...
I'm a professor of medicine at Harvard Medical School and medical oncologist at Dana-Farber Cancer Institute in Boston, ...
You know, one of the big pushes now is to really understand for patients presenting with de novo metastatic disease, is it ...
UNLOXCYT is an evolution in checkpoint inhibition and is now available for the treatment of adults in the U.S. with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC ...
9h
Anthony Galluccio Uses Platform to Spotlight Childhood Cancer, Youth Sports, and Smart Development
Attorney and former mayor calls for everyday action to strengthen families and communities CAMBRIDGE, MA / ACCESS Newswire / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback